Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TFCP2L1 - Pretreatment breast needle biopsies of locally advanced breast cancer
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TFCP2L1 - Lung metastatic breast cancer cell line response to metadherin depletion
TFCP2L1 - Clear cell renal cell carcinoma (HB-U133B)
TFCP2L1 - Cystic fibrosis patients with mild and severe lung disease: nasal respiratory epithelium (HG-U133B)
TFCP2L1 - Renal clear cell carcinoma (HG-U133B)
TFCP2L1 - Long-term adult survivors of glioblastoma: primary tumors
TFCP2L1 - Pregnancy-associated breast cancer: laser capture microdissected epithelia and stroma
TFCP2L1 - Clear-cell renal cell carcinoma tumors and tumorgrafts deficient for tumor suppressor BAP1 or PBRM1
TFCP2L1 - Stage III serous ovarian adenocarcinomas
GEO DataSets Gene Chromosome neighbors Homologene neighbors
TFCP2L1 - Chromophobe renal cell carcinoma and oncocytoma
TFCP2L1 - Chemoresistant glioblastomas: expression profile
TFCP2L1 - NeOAdjuvant Herceptin (NOAH) trial: formalin-fixed, paraffin-embedded breast cancer biopsies
TFCP2L1 - Mucociliary differentiation of airway epithelial cells
TFCP2L1 - Normal tissues of diverse types (SHBW)
TFCP2L1 - Lymphoblastoid cell lines from CEPH/Utah families
TFCP2L1 - Estrogen positive breast cancer recurrence during tamoxifen therapy: microdissected tumor
TFCP2L1 - Estrogen positive breast cancer recurrence during tamoxifen therapy: whole tissue tumor
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on